Skip to main content
Download available--Arthritis Myths

https://t.co/2Kxpou4Fbz

Dr. John Cush RheumNow

5 years 7 months ago
Download available--Arthritis Myths https://t.co/2Kxpou4Fbz
RheumNow LIVE VOTE Survey (RHEUMS only):
What Kind of Rheumatologist are You?
General Rheum?
Selective Rheum?
Specializ

Dr. John Cush RheumNow

5 years 7 months ago
RheumNow LIVE VOTE Survey (RHEUMS only): What Kind of Rheumatologist are You? General Rheum? Selective Rheum? Specialized Rheum? please vote in our quick 4Q survey https://t.co/2c5fIgcJ5X https://t.co/LgK8yiXEWC
Influenza Numbers are way down this year due to COVID mitigation methods, school/office closings, reduced travel/mobilit

Dr. John Cush RheumNow

5 years 7 months ago
Influenza Numbers are way down this year due to COVID mitigation methods, school/office closings, reduced travel/mobility. As of Jan 31st only 155 hospitalized with the flu (98% less than 2019-2020 flu season - 8,633 people were hospitalized with the flu) https://t.co/6c2YQKbt57?
QD Clinic - RA and LFTs
2021 Rheumatollgy drugs lead television advertising spending: #1 Humira ($65.8 million); #6 Xeljanz ($33.9 mill); #7

Dr. John Cush RheumNow

5 years 7 months ago
2021 Rheumatollgy drugs lead television advertising spending: #1 Humira ($65.8 million); #6 Xeljanz ($33.9 mill); #7 Skyrizi ($40 mill); #8 Enbrel ($25.8mill); #9 Rinvo ($12+ mill) https://t.co/Pan9Vr5kLt
Dr. Jack Cush reviews and discusses nearly a dozen news reports and journal articles from the past week on RheumNow.com.
Today the FDA approved tocilizumab (Actemra) for use in Systemic Sclerosis-Associated Interstitial Lung Disease for "Slo

Dr. John Cush RheumNow

5 years 7 months ago
Today the FDA approved tocilizumab (Actemra) for use in Systemic Sclerosis-Associated Interstitial Lung Disease for "Slowing the rate of decline in pulmonary function in adult patients with SSc-ILD" Rec dose is 162 mg SC q week (IV dose not approved) https://t.co/HXTRPiYEfZ
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians.

Sign up to atte

Dr. John Cush RheumNow

5 years 7 months ago
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians. Sign up to attend virtually today. https://t.co/9IGCDMnlrb
Comparison of MSU crystal ID, DECT scanning and US to Dx gout - study of 147 pts. Compared to the gold standard (MSU ID)

Dr. John Cush RheumNow

5 years 7 months ago
Comparison of MSU crystal ID, DECT scanning and US to Dx gout - study of 147 pts. Compared to the gold standard (MSU ID), Feet/ankles (87% sensitivity; 100% specificity) or knees DECT (91% & 87%) alone had best Dx accuracy. US was inferior to DECT. https://t.co/h8ctkfeadZ
QD Clinic - Remission Time
×